• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov9
Otsuka Holdings Announces Positive Interim Results for Phase III Trial of IGA Nephropathy Treatment Drug
23:56
Oct31
Otsuka Pharmaceutical released FY2025 Q3 earnings on October 31 During-Market (EST), actual revenue USD 4.292 B (forecast USD 4.251 B), actual EPS USD 0.7907
20:00
Otsuka Pharmaceutical released FY2025 9 Months Earnings on October 31 During-Market (EST), actual revenue USD 12.31 B, actual EPS USD 1.8991
20:00
Otsuka Pharmaceutical Profits Up 27% in Nine Months
09:28
Oct23
Otsuka Pharmaceutical to Release FY2025 Q3 Earnings on October 30 During-Market EST, Forecast Revenue USD 4.275 B
00:07
Sep20
H. Lundbeck A/S and Otsuka receive FDA response on PTSD treatment application and plan for additional trials
06:00

Schedules & Filings

Schedules
Filings
Oct31
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 4.292 B, Net Income 835.15 M, EPS 0.7907

Jul31
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.131 B, Net Income 611.59 M, EPS 0.5789

Jun30
Distribution Plan(EST)

Cash dividend 0.2036 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
CDTX
218.300
+105.96%
+112.380
WTO
0.0337
+68.50%
+0.014
CYPH
2.880
+63.63%
+1.110
IVVD
2.580
+45.76%
+0.830
BCG
1.985
+39.32%
+0.560
TOI
4.115
+33.60%
+1.035
EPWK
0.0527
+30.77%
+0.012
PGEN
5.045
+30.70%
+1.185
YDES
12.850
+26.98%
+2.730
ENGS
2.051
+26.59%
+0.431
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy